deltatrials
Unknown PHASE2 INTERVENTIONAL 3-arm NCT02966964

A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV

An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)

Sponsor: Daewoong Pharmaceutical Co. LTD.

Conditions Hepatitis; Virus, Chronic, Type B
Interventions DWPUR001 Placebo
Updated 8 times since 2017 Last updated: Sep 21, 2017 Started: Apr 30, 2015 Primary completion: Nov 30, 2018 Completion: Feb 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hepatitis; Virus, Chronic, Type B and is currently ongoing. Daewoong Pharmaceutical Co. LTD. leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Oct 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Oct 2019 [monthly]

    Recruiting PHASE2

  2. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Daewoong Pharmaceutical Co. LTD.
  • Uijeongbu St. Mary Hospital
Data source: Uijeongbu St. Mary Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations